Skip to main content
Equibles

Douglas Love

CEO

Annexon, Inc. (ANNX)

Board Member

Annexon, Inc. (ANNX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Annexon, Inc. publishes a filing, an earnings call transcript or a press release.

Get ANNX alerts

About Douglas Love

Douglas Love is recorded as CEO and Board Member at Annexon, Inc. (ANNX). The newest filing on record that lists Douglas Love as CEO and Board Member at Annexon, Inc. (ANNX) is dated April 27, 2026. The proxy statement of Annexon, Inc. reports total compensation of $3,579,202 for Douglas Love in fiscal 2025, including a base salary of $670,833. Disclosed compensation is on record for 7 fiscal years. Douglas Love has spoken on 5 investor events across 1 company, most recently for Annexon, Inc. on September 9, 2026. Annexon, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Annexon, Inc. includes Jennifer Lew (CFO), Ted Yednock, Ph.D. (CIO), Bettina M. Cockroft (Board Member) and 4 others.

Douglas Love on recent calls

“So we're in our 11th year here at the Nexon, and more excited than ever about the technology that underpins the company.”
CEO, Wells Fargo 21st Annual Healthcare Conference ·
“It's delightful to be out here in Miami with you all. So, look, we're really excited about the phase three asset of on-approvement for the treatment of geographic atrophy.”
CEO, Goldman Sachs 47th Annual Global Healthcare Conference ·
“So thanks, everyone, for joining us today. We're very delighted to be at this year's Jefferies Conference. So as Andrew said, I'm Doug Love, CEO and President of Anexon Biosciences.”
CEO, Jefferies Global Healthcare Conference ·
“An Exxon is a leading neuroimmunology company, Sarah, a little tongue-tied there. It has been already. Anyway, we're targeting complement, which many of you are familiar with, of a very differentiated approach.”
CEO, Bank of America Securities Health Care Conference ·
“We always appreciate this conference, an opportunity to talk to folks. Super excited about 2026. So as you know, we've been on a 12-year journey to get to this year.”
CEO, 25th Annual Needham Virtual Healthcare Conference ·

Affiliation history

  • Annexon, Inc. (ANNX)

    CEO

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 27, 2026

  • Annexon, Inc. (ANNX)

    Board Member

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 27, 2026

Company network

Leadership on record at Annexon, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Annexon, Inc. (ANNX) $670,833 $3,579,202
2024 Annexon, Inc. (ANNX) $641,099 $3,672,746
2023 Annexon, Inc. (ANNX) $593,380 $2,453,184
2022 Annexon, Inc. (ANNX) $568,642 $3,582,434
2021 Annexon, Inc. (ANNX) $533,883 $8,069,473
2020 Annexon, Inc. (ANNX) $445,960 $4,602,462
2019 Annexon, Inc. (ANNX) $395,520 $3,388,240

Recent activity